SMI
11.990,27
PKT
+48,27
PKT
+0,40
%
Werbung
Analysen zu SMI-Werten
Datum | Rating | Analyst | |
---|---|---|---|
19.12.16 | Novartis buy | Jefferies & Company Inc. | |
19.12.16 | UBS buy | Citigroup Corp. | |
19.12.16 | UBS buy | Citigroup Corp. | |
16.12.16 | Swiss Re Hold | Société Générale Group S.A. (SG) | |
15.12.16 | UBS buy | Kepler Cheuvreux | |
15.12.16 | UBS Reduce | Kepler Cheuvreux | |
14.12.16 | Zurich Insurance overweight | JP Morgan Chase & Co. | |
14.12.16 | UBS Hold | Deutsche Bank AG | |
14.12.16 | UBS Hold | Deutsche Bank AG | |
14.12.16 | Nestlé Neutral | BNP PARIBAS | |
14.12.16 | Holcim Neutral | Merrill Lynch & Co., Inc. | |
13.12.16 | Nestlé buy | Deutsche Bank AG | |
13.12.16 | Novartis Hold | Deutsche Bank AG | |
13.12.16 | Swiss Re overweight | JP Morgan Chase & Co. | |
13.12.16 | Novartis overweight | JP Morgan Chase & Co. | |
13.12.16 | Swiss Re buy | Deutsche Bank AG | |
13.12.16 | ABB (Asea Brown Boveri) overweight | Barclays Capital | |
13.12.16 | ABB (Asea Brown Boveri) Underperform | Jefferies & Company Inc. | |
13.12.16 | Novartis buy | HSBC | |
13.12.16 | Zurich Insurance Outperform | Credit Suisse Group | |
12.12.16 | ABB (Asea Brown Boveri) overweight | Morgan Stanley | |
12.12.16 | Zurich Insurance overweight | Barclays Capital | |
12.12.16 | Swiss Re Underweight | Barclays Capital | |
12.12.16 | UBS overweight | JP Morgan Chase & Co. | |
12.12.16 | UBS Neutral | JP Morgan Chase & Co. | |
12.12.16 | Swiss Re Underperform | Credit Suisse Group | |
09.12.16 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
09.12.16 | UBS buy | HSBC | |
09.12.16 | Holcim buy | Deutsche Bank AG | |
09.12.16 | UBS Hold | Deutsche Bank AG | |
09.12.16 | UBS buy | UBS AG | |
08.12.16 | Zurich Insurance Hold | Jefferies & Company Inc. | |
08.12.16 | UBS overweight | JP Morgan Chase & Co. | |
08.12.16 | Swiss Re Underperform | Jefferies & Company Inc. | |
08.12.16 | Swiss Re buy | Deutsche Bank AG | |
08.12.16 | UBS buy | Kepler Cheuvreux | |
08.12.16 | UBS neutral | Morgan Stanley | |
08.12.16 | Zurich Insurance buy | HSBC | |
08.12.16 | Roche buy | UBS AG | |
08.12.16 | Novartis Neutral | UBS AG |
* Die angezeigten Realtime Kurse sind indikativ und nicht die offiziellen Börsenkurse. Die Kursdaten können eventuell vom tatsächlichen Marktpreis abweichen.